Sridhar Nambi is an Endocrinology/Metabolic physician affiliated with Saint Barnabas Medical Center. OpenAlex indexes 9 publications with 4,219 citations (h-index 7).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
22 Old Short Hills Rd
Suite 201
Livingston, NJ 07039
Telephone
973-535-8870Provider last certified this registry record 8 Apr 2024.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Novo Nordisk IncProgram year20252 payments
- Abbott LaboratoriesProgram year20251 payment
- Novo Nordisk IncProgram year20244 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
70.4%Biguanide (metformin)16.8%Metformin Hcl Er52%Metformin Hcl48%Part D≥70 patientsInsulin Analog15.8%Humalog Kwikpen U-10025%Lantus Solostar25%Toujeo Solostar9%Basaglar Kwikpen U-1007%Novolog Flexpen6%Xultophy 100-3.66%Tresiba Flextouch U-1006%Soliqua 100-335%Tresiba Flextouch U-2004%Humalog4%Levemir Flexpen4%Part D<11 patients+ 8 more classes in this area
Hormonal (systemic)
20.4%l-Thyroxine19%Levothyroxine Sodium78%Synthroid22%Part D≥120 patientsThyroid Hormone Synthesis Inhibitor0.8%Methimazole100%Part D<11 patients+ 1 more class in this area
Cardiovascular
7.9%Statin5.1%Atorvastatin Calcium43%Rosuvastatin Calcium39%Simvastatin18%Part D<11 patientsAngiotensin receptor blocker (ARB)0.8%Losartan Potassium100%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Adrenal Crisis Secondary to COVID-19 Vaccination in a Patient With Hypopituitarism
AACE Clinical Case Reports
2022 - SAT-LB89 Choriocarcinoma Induced Hyperthyroidism: Molecular Mimicry Between HCG and TSH
Journal of the Endocrine Society
2020 - SUN-LB031 An Atypical Case of Diabetic Keto-Alkalosis with Severe Hypernatremic Hyperosmolarity in a Patient with Amphetamine Abuse
Journal of the Endocrine Society
2019 - Retrospective Analysis of Early Steroid-Induced Adverse Reactions in Kidney and Kidney-Pancreas Transplant Recipients
Transplantation Proceedings
2007
Similar KOLs
Other experts from the same institution or the same specialty.
Marjorie Luckey, MD
Saint Barnabas Medical Center
Franz Smith, MD
Saint Barnabas Medical Center
Francis Weng, MD
Saint Barnabas Medical Center
Dom Terrone, MD
Saint Barnabas Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”